High-affinity, blocking antibodies — guaranteed
Find the best solution for your discovery project.
Talk to our experts
Derisk your project, secure reliable results
No Win – No Fee Guarantee
At ProteoGenix, we harness the synergy of AI-driven discovery, expert wet-lab execution, and one of the most diverse antibody generation platforms on the market. This unique approach allows us to address even your most complex R&D challenges with complete confidence.
If we don’t deliver binders, you pay nothing for the service—simple as that. It’s more than a promise; it’s our commitment to your success.
Explore our discovery innovations
🔹 Phage Display on Libraries
Unlock billions of antibody possibilities with Phage Display — the proven powerhouse for rapid candidate discovery.
Ideal when you need massive diversity and in silico-driven selection to quickly identify unique binders.
🔹 Single B Cell on Humanized Mice
Go straight to nature’s best solutions with Single B Cell from humanized mice — precise, high-affinity antibodies in record time.
Best for projects aiming at fully human, high-affinity antibodies with strong clinical translation potential.
🔹 Hybridoma
Rely on the gold standard: Hybridoma delivers robust, consistent monoclonal antibodies trusted for decades.
Perfect if you need tried-and-true reliability and reproducibility, especially for long-term research use.
Testimonial of Trident Biopharm Solutions
Project: New Antibody Cocktail Effective Against Major Variants of SARS-CoV-2
“I requested ProteoGenix’s services for the generation of neutralizing anti-COVID-19 antibodies by Phage Display. They designed an optimised strategy for this purpose which led to great results, with 4 antibodies identified as cross-reactive and neutralizing against all the current variants of concerns. During the whole project, Proteogenix strived to ensure the best quality of their final deliverables, especially by including additional screenings against emerging variants as the pandemic evolved. Their proactivity was key to obtaining promising and relevant blocking antibodies in only a few months. I highly recommend them for both their level of expertise and the personalised service they offer.”
Khelan Patel, Managing Director, Trident Biopharm Solutions, London, UK
Scientific corner - Read our article on Single B Cell
How Can Single B Cell Sorting Propel Your Antibody Discovery to New Heights?
In the ever-evolving field of biotechnology, the quest for innovative and effective antibody discovery methods is relentless. Researchers and scientists are continually seeking ways to enhance therapeutic, diagnostic, and research applications. Enter Single B Cell Sorting—a groundbreaking technology that's set to revolutionize antibody discovery. Imagine being able to isolate individual B cells with pinpoint precision, rapidly develop high-affinity antibodies, and tackle complex diseases with unprecedented accuracy. This isn't a future dream; it's the reality of Single B Cell Sorting.
Curious about how this cutting-edge technology can propel your antibody discovery to new heights?